113 related articles for article (PubMed ID: 23796562)
1. A sequence polymorphism in miR-608 predicts recurrence after radiotherapy for nasopharyngeal carcinoma.
Zheng J; Deng J; Xiao M; Yang L; Zhang L; You Y; Hu M; Li N; Wu H; Li W; Lu J; Zhou Y
Cancer Res; 2013 Aug; 73(16):5151-62. PubMed ID: 23796562
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism in mature microRNA-608 sequence is associated with an increased risk of nasopharyngeal carcinoma.
Qiu F; Yang L; Zhang L; Yang X; Yang R; Fang W; Wu D; Chen J; Xie C; Huang D; Zhou Y; Lu J
Gene; 2015 Jul; 565(2):180-6. PubMed ID: 25861865
[TBL] [Abstract][Full Text] [Related]
3. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
[TBL] [Abstract][Full Text] [Related]
4. Association between single nucleotide polymorphisms in the p53 pathway and response to radiotherapy in patients with nasopharyngeal carcinoma.
Xie X; Jin H; Hu J; Zeng Y; Zhou J; Ouyang S; Yang W; Hu B; Wang H
Oncol Rep; 2014 Jan; 31(1):223-31. PubMed ID: 24173110
[TBL] [Abstract][Full Text] [Related]
5. The impacts of single nucleotide polymorphisms in genes of cell cycle and NF-kB pathways on the efficacy and acute toxicities of radiotherapy in patients with nasopharyngeal carcinoma.
Guo C; Huang Y; Yu J; Liu L; Gong X; Huang M; Jiang C; Liao Y; Huang L; Yang G; Li J
Oncotarget; 2017 Apr; 8(15):25334-25344. PubMed ID: 28445979
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of Wnt/β-catenin pathway genes are associated with the efficacy and toxicities of radiotherapy in patients with nasopharyngeal carcinoma.
Yu J; Huang Y; Liu L; Wang J; Yin J; Huang L; Chen S; Li J; Yuan H; Yang G; Liu W; Wang H; Pei Q; Guo C
Oncotarget; 2016 Dec; 7(50):82528-82537. PubMed ID: 27769064
[TBL] [Abstract][Full Text] [Related]
7. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
[TBL] [Abstract][Full Text] [Related]
8. Acute oral mucositis in nasopharyngeal carcinoma patients treated with radiotherapy: association with genetic polymorphism in DNA DSB repair genes.
Ren JH; Dai XF; Yan GL; Jin M; Liu CW; Yang KY; Wu G; Ma CM
Int J Radiat Biol; 2014 Mar; 90(3):256-61. PubMed ID: 24350917
[TBL] [Abstract][Full Text] [Related]
9. Association of CELF2 polymorphism and the prognosis of nasopharyngeal carcinoma in southern Chinese population.
Guo YM; Sun MX; Li J; Liu TT; Huang HZ; Chen JR; Liu WS; Feng QS; Chen LZ; Bei JX; Zeng YX
Oncotarget; 2015 Sep; 6(29):27176-86. PubMed ID: 26314850
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
[TBL] [Abstract][Full Text] [Related]
11. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
[TBL] [Abstract][Full Text] [Related]
12. Association of miRNA-related genetic polymorphisms and prognosis in patients with esophageal squamous cell carcinoma.
Yang PW; Huang YC; Hsieh CY; Hua KT; Huang YT; Chiang TH; Chen JS; Huang PM; Hsu HH; Kuo SW; Kuo ML; Lee JM
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S601-9. PubMed ID: 24770678
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.
Zhang LY; Ho-Fun Lee V; Wong AM; Kwong DL; Zhu YH; Dong SS; Kong KL; Chen J; Tsao SW; Guan XY; Fu L
Carcinogenesis; 2013 Feb; 34(2):454-63. PubMed ID: 23125220
[TBL] [Abstract][Full Text] [Related]
14. MiR-185-3p and miR-324-3p Predict Radiosensitivity of Nasopharyngeal Carcinoma and Modulate Cancer Cell Growth and Apoptosis by Targeting SMAD7.
Xu J; Ai Q; Cao H; Liu Q
Med Sci Monit; 2015 Sep; 21():2828-36. PubMed ID: 26390174
[TBL] [Abstract][Full Text] [Related]
15. microRNA expression profiling of nasopharyngeal carcinoma.
Li T; Chen JX; Fu XP; Yang S; Zhang Z; Chen KhH; Li Y
Oncol Rep; 2011 May; 25(5):1353-63. PubMed ID: 21373758
[TBL] [Abstract][Full Text] [Related]
16. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
[TBL] [Abstract][Full Text] [Related]
17. Differential miRNA expression in repeated recurrence of nasopharyngeal carcinoma.
Wang LJ; Chou YF; Chen PR; Su B; Hsu YC; Chang CH; Lee JW
Cancer Lett; 2014 Mar; 344(2):188-94. PubMed ID: 24183849
[TBL] [Abstract][Full Text] [Related]
18. miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma.
Zhao L; Tang M; Hu Z; Yan B; Pi W; Li Z; Zhang J; Zhang L; Jiang W; Li G; Qiu Y; Hu F; Liu F; Lu J; Chen X; Xiao L; Xu Z; Tao Y; Yang L; Bode AM; Dong Z; Zhou J; Fan J; Sun L; Cao Y
Oncotarget; 2015 Jun; 6(18):15995-6018. PubMed ID: 26201446
[TBL] [Abstract][Full Text] [Related]
19. Clinical Analysis of Recurrence Patterns in Patients With Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy.
Wang L; Guo Y; Xu J; Chen Z; Jiang X; Zhang L; Huang S; He X; Zhang Y
Ann Otol Rhinol Laryngol; 2017 Dec; 126(12):789-797. PubMed ID: 29025277
[TBL] [Abstract][Full Text] [Related]
20. Impact of polymorphisms in angiogenesis-related genes on clinical outcomes of radiotherapy in patients with nasopharyngeal carcinoma.
Ma WL; Liu R; Huang LH; Zou C; Huang J; Wang J; Chen SJ; Meng XG; Yang JK; Li H; Yang GP; Guo CX
Clin Exp Pharmacol Physiol; 2017 May; 44(5):539-548. PubMed ID: 28199751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
